NeoGenomics launches blood-based cancer test PanTracer LBx
Go back to NeoGenomics launches blood-based cancer test PanTracer LBx| NEOGENOMICS (NASDAQ: NEO) | Delayed: 18.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.64 | 52 Week High | $9.54 | |||
| Open | $18.64 | 52 Week Low | $5.49 | |||
| Day High | $18.64 | P/E | 466.00 | |||
| Day Low | $18.64 | EPS | $0.04 | |||
| Volume | 869 | |||||

